News

Sufentanil TDS is a matrix-type transdermal patch with the active ingredient sufentanil, a highly potent opioid analgesic that is used as an injection or infusion for anesthesia and

CTI said that the application submission follows a positive opinion from the EMA’s Pediatric Committee (the PDCO), where PDCO agreed to CTI’s Pediatric Investigation Plan (PIP) for Pixuvri.

The safety and effectiveness of Teflaro was evaluated in four, Phase 3 clinical trials in patients ages 18 years and older (two each in CABP and in ABSSSI).

Valino served as an operating partner with Advent International, a global private equity firm, where he focused on investment opportunities in the Latin American health care industry. From

Helix BioPharma said that the product revenue contributed to the increase in revenue in fiscal 2010 when compared to fiscal 2009 and was offset slightly by a decrease

Gilead’s three-arm Phase IIa trial evaluated the safety and efficacy of GS 9190, an oral polymerase inhibitor, in combination with GS 9256, an oral protease inhibitor, when used

Study 204 was a randomised, double-blind, placebo-controlled, two arm study of a single oral dose of 600 mg of NXN-188 for the treatment of moderate to severe acute

Avanir Pharma president and CEO Keith Katkin said that the FDA approval of Nuedexta marks an important milestone for people living with PBA. "The approval of Nuedexta also

Idenix Pharma has posted a net loss of $12.93m for the third quarter 2010, or $0.18 per diluted share, compared to $11.67m, or $0.18 per diluted share, for